BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 21444725)

  • 1. Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells.
    de Zoeten EF; Wang L; Butler K; Beier UH; Akimova T; Sai H; Bradner JE; Mazitschek R; Kozikowski AP; Matthias P; Hancock WW
    Mol Cell Biol; 2011 May; 31(10):2066-78. PubMed ID: 21444725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms.
    Beier UH; Wang L; Han R; Akimova T; Liu Y; Hancock WW
    Sci Signal; 2012 Jun; 5(229):ra45. PubMed ID: 22715468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone/protein deacetylase 11 targeting promotes Foxp3+ Treg function.
    Huang J; Wang L; Dahiya S; Beier UH; Han R; Samanta A; Bergman J; Sotomayor EM; Seto E; Kozikowski AP; Hancock WW
    Sci Rep; 2017 Aug; 7(1):8626. PubMed ID: 28819166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells.
    Beier UH; Akimova T; Liu Y; Wang L; Hancock WW
    Curr Opin Immunol; 2011 Oct; 23(5):670-8. PubMed ID: 21798734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice.
    de Zoeten EF; Wang L; Sai H; Dillmann WH; Hancock WW
    Gastroenterology; 2010 Feb; 138(2):583-94. PubMed ID: 19879272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.
    Bali P; Pranpat M; Bradner J; Balasis M; Fiskus W; Guo F; Rocha K; Kumaraswamy S; Boyapalle S; Atadja P; Seto E; Bhalla K
    J Biol Chem; 2005 Jul; 280(29):26729-34. PubMed ID: 15937340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3.
    Wang L; Liu Y; Han R; Beier UH; Bhatti TR; Akimova T; Greene MI; Hiebert SW; Hancock WW
    J Clin Invest; 2015 Mar; 125(3):1111-23. PubMed ID: 25642770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Histone Deacetylase 6 Reveals a Potent Immunosuppressant Effect in Models of Transplantation.
    Ellis JD; Neil DA; Inston NG; Jenkinson E; Drayson MT; Hampson P; Shuttleworth SJ; Ready AR; Cobbold M
    Transplantation; 2016 Aug; 100(8):1667-74. PubMed ID: 27222932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deacetylase inhibition promotes the generation and function of regulatory T cells.
    Tao R; de Zoeten EF; Ozkaynak E; Chen C; Wang L; Porrett PM; Li B; Turka LA; Olson EN; Greene MI; Wells AD; Hancock WW
    Nat Med; 2007 Nov; 13(11):1299-307. PubMed ID: 17922010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells.
    Kalin JH; Butler KV; Akimova T; Hancock WW; Kozikowski AP
    J Med Chem; 2012 Jan; 55(2):639-51. PubMed ID: 22165909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs.
    Akimova T; Ge G; Golovina T; Mikheeva T; Wang L; Riley JL; Hancock WW
    Clin Immunol; 2010 Sep; 136(3):348-63. PubMed ID: 20478744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited efficacy of specific HDAC6 inhibition in urothelial cancer cells.
    Rosik L; Niegisch G; Fischer U; Jung M; Schulz WA; Hoffmann MJ
    Cancer Biol Ther; 2014 Jun; 15(6):742-57. PubMed ID: 24618845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors modulate interleukin 6-dependent CD4+ T cell polarization in vitro and in vivo.
    Glauben R; Sonnenberg E; Wetzel M; Mascagni P; Siegmund B
    J Biol Chem; 2014 Feb; 289(9):6142-51. PubMed ID: 24421314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving allogeneic islet transplantation by suppressing Th17 and enhancing Treg with histone deacetylase inhibitors.
    Sugimoto K; Itoh T; Takita M; Shimoda M; Chujo D; SoRelle JA; Naziruddin B; Levy MF; Shimada M; Matsumoto S
    Transpl Int; 2014 Apr; 27(4):408-15. PubMed ID: 24410777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC.
    Ojha R; Huang HL; HuangFu WC; Wu YW; Nepali K; Lai MJ; Su CJ; Sung TY; Chen YL; Pan SL; Liou JP
    Eur J Med Chem; 2018 Apr; 150():667-677. PubMed ID: 29567459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitor regulates the balance of Th17/Treg in allergic asthma.
    Hou X; Wan H; Ai X; Shi Y; Ni Y; Tang W; Shi G
    Clin Respir J; 2016 May; 10(3):371-9. PubMed ID: 25307458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NBM-T-BBX-OS01, Semisynthesized from Osthole, Induced G1 Growth Arrest through HDAC6 Inhibition in Lung Cancer Cells.
    Pai JT; Hsu CY; Hua KT; Yu SY; Huang CY; Chen CN; Liao CH; Weng MS
    Molecules; 2015 May; 20(5):8000-19. PubMed ID: 25946558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubacin, an HDAC6 Selective Inhibitor, Reduces the Replication of the Japanese Encephalitis Virus via the Decrease of Viral RNA Synthesis.
    Lu CY; Chang YC; Hua CH; Chuang C; Huang SH; Kung SH; Hour MJ; Lin CW
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics.
    Laino AS; Betts BC; Veerapathran A; Dolgalev I; Sarnaik A; Quayle SN; Jones SS; Weber JS; Woods DM
    J Immunother Cancer; 2019 Feb; 7(1):33. PubMed ID: 30728070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role of mitochondrial energy metabolism in Foxp3⁺ T-regulatory cell function and allograft survival.
    Beier UH; Angelin A; Akimova T; Wang L; Liu Y; Xiao H; Koike MA; Hancock SA; Bhatti TR; Han R; Jiao J; Veasey SC; Sims CA; Baur JA; Wallace DC; Hancock WW
    FASEB J; 2015 Jun; 29(6):2315-26. PubMed ID: 25681462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.